Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study of Epcoritamab as a Consolidation Therapy in CLL/SLL

This is a phase 2 study of Epcoritamab as a consolidation therapy for 2nd generation BTKi +/- Obinutuzumab in CLL/SLL patients or patients with variants of this.

Participants needed: 22
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Zulfa OmerUpdated: Jan 6, 2026Locations: 1
Eligibility criteria

Diagnosis of CLL or SLL meeting the established 2018 iwCLL diagnostic criteria o... [+10]

Obtaining a CR or nodal PR with no detectable disease in blood or bone marrow af... [+17]

Read more
Status: Recruiting

Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL

This is a randomized Phase II study of intermittent versus continuous venetoclax therapy with Acalabrutinib in previously untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Participants needed: 62
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Zulfa OmerUpdated: Jan 6, 2026Locations: 1
Eligibility criteria

Diagnosis of Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (S... [+12]

Evidence of any active concurrent disease (such as severe or uncontrolled system... [+25]

Read more
Status: Recruiting

LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This

Multicenter Parallel 2 Cohort Phase 2 Study of LP-168 and Obinutuzumab for Previously Treated, and T474 Gatekeeper Mutant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This.

Participants needed: 34
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Zulfa OmerUpdated: Aug 14, 2025Locations: 1
Eligibility criteria

Diagnosis of CLL or SLL meeting criteria established in the 2018 iwCLL criteria... [+16]

Patients with active Richter's transformation. [+36]

Read more